Solugen
Solugen is a chemical manufacturing company that operates the Bioforge, the world's first carbon-negative molecule factory using plant-based feedstocks.
Secondary Market Price
How Solugen Measures Up
To help you manage your Solugen equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series D
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Solugen's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Solugen Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Solugen's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Solugen is a chemical manufacturing company that develops and produces chemical solutions from sustainable feedstocks. The company operates a carbon-negative molecule factory, the Bioforge, which utilizes enzymes, plant-based materials, and clean catalytic reactions to create products for sectors including energy, defense, industrial systems, and personal care. Its offerings range from corrosion and scale inhibitors for oil and gas to additives for water treatment and ingredients for skin care. Founded in 2016 by Gaurab Chakrabarti and Sean Hunt, the Houston-based company has expanded from lab-scale development to large-scale manufacturing.
The company plans to establish additional carbon-negative molecule factories across the United States to scale its biomanufacturing platform, with a focus on supporting U.S. defense and industrial resilience. In 2024, Solugen announced a partnership with American Rheinmetall Munitions to expand the domestic supply of energetic materials for the defense industry. Other recent developments include securing $213.6 million in debt financing in July 2024. The company also reported shipping over 120 million pounds of products in 2024 and doubling its production capacity in six months.
- Baillie Gifford
- GIC
- Temasek Holdings
- BlackRock
- Founders Fund
- Fifty Years
- Refactor Capital
- Kinnevik
- Lowercarbon Capital
- Y Combinator
- Co-Founder, Gaurab Chakrabarti
- Co-Founder, Sean Hunt
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Solugen worth joining?
Deciding whether to join Solugen requires evaluating your potential role, the company's trajectory, and the total compensation package. Tools like Prospect can help you model the potential value of your equity offer to make a more informed decision.
What should I do with my Solugen stock?
Managing your Solugen stock involves creating a strategy that aligns with your financial goals, risk tolerance, and tax situation. Platforms like Prospect offer customized option exercise and stock sale strategies to help you maximize your earnings.
Can you sell Solugen stock?
As Solugen is a private company, selling stock is generally possible only during company-approved liquidity events, such as tender offers. Prospect provides tools to help you navigate these opportunities and determine the tax-optimal shares to sell.
How can I find the value of my Solugen stock?
The value of private stock like Solugen's is typically determined by its 409A valuation, which is based on the most recent funding round. For a more dynamic valuation, Prospect uses predictive models to forecast your equity's potential future value.
What is Solugen's equity worth?
The precise worth of Solugen's equity is not public information and depends on the company's private valuation. You can use a platform like Prospect to analyze various data points and model a range of potential outcomes for your equity's value.
What is Solugen's stock ticker symbol?
Since Solugen is a private company, it is not listed on a public stock exchange and therefore does not have a stock ticker symbol. Ticker symbols are only assigned to companies once they undergo an Initial Public Offering (IPO).
Can I buy or sell Solugen stock?
As an employee, you can typically "buy" stock by exercising your vested options, but selling is restricted to specific liquidity events like tender offers. Prospect offers guidance on both exercising options and selling shares to optimize your financial outcome.
What is the criteria to buy or invest in Solugen stock?
Investing in a private company like Solugen is typically restricted to employees receiving equity compensation or accredited investors participating in funding rounds. For employees, Prospect can help analyze the financial implications of exercising your options, which is a form of investment in the company.
